A clinical and serologic comparison of African American and Caucasian patients with systemic sclerosis.
A clinical and serologic comparison of African American and Caucasian patients with systemic sclerosis.
复制标题
DOI:
10.1002/art.34482
复制
发表时间:
2012-09
影响因子:
--
通讯作者:
Medsger, Thomas A., Jr.
中科院分区:
文献类型:
--
作者:
Steen, Virginia;Domsic, Robyn T.;Lucas, Mary;Fertig, Noreen;Medsger, Thomas A., Jr.
Epidemiology studies suggest that Systemic Sclerosis is more common, occurs at a younger age and is more severe in African-Americans than Caucasians. However, the scleroderma autoantibody profile is very different between these two ethnic subgroups. This study examines the demographic and disease features, frequency and severity of internal organ system involvement and survival in African-American and Caucasian SSc patients with particular attention to their serum autoantibody profiles. Demographic, clinical, autoantibody, natural history of organ involvement and survival were studied in consecutive African-American and Caucasian patients seen between 1972 and 2007 as part of the Pittsburgh Scleroderma Database. The Medsger Disease Severity Scale was used to determine severe disease. African-American patients were more likely to have anti topoisomerase, anti U1RNP and U3 RNP auto-antibodies. Comparing African-American and Caucasians with these antibodies, African-American patients with anti topoisomerase antibody had more frequent and more severe pulmonary fibrosis than Caucasians and an associated decreased survival. Pulmonary fibrosis was also more severe in the U1 RNP patients but was not associated with a difference in survival between African Americans and Caucasians. Anti U3 RNP was associated with more severe gastrointestinal involvement in African-American’s compared to Caucasians. African Americans with systemic sclerosis have more severe disease complications than Caucasians both because of the type of autoantibody they have and because they have more severe interstitial lung disease even within the antibody subset. Early aggressive intervention in all African Americans with interstitial lung disease should be a priority.
登录
查看更多内容
影响因子:
3.9
作者:
Sharif, Roozbeh;Fritzler, Marvin J.;Arnett, Frank C.
通讯作者:
Arnett, Frank C.
DOI:
10.1002/art.22532
发表时间:
2007-03-15
期刊:
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH
影响因子:
--
作者:
McNearney, Terry A.;Reveille, John D.;Mayes, Maureen D.
通讯作者:
Mayes, Maureen D.
影响因子:
--
作者:
Steen, VD;Oddis, CV;Medsger, TA
通讯作者:
Medsger, TA
影响因子:
39.2
作者:
OKANO, Y;STEEN, VD;MEDSGER, TA
通讯作者:
MEDSGER, TA
影响因子:
27.4
作者:
Steen, Virginia D.;Medsger, Thomas A.
通讯作者:
Medsger, Thomas A.